Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 10,000 shares at $6.30 ($63K) on 2023-06-08, disclosed to the SEC on 2023-06-09.
Open-market sale of $63k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |